167 related articles for article (PubMed ID: 11300102)
1. Application of magnetic resonance imaging to angiogenesis in breast cancer.
Leach MO
Breast Cancer Res; 2001; 3(1):22-7. PubMed ID: 11300102
[TBL] [Abstract][Full Text] [Related]
2. [Dynamic MRI and tumor angiogenesis of breast cancer].
Yasumura K; Ogawa K; Yuasa Y; Hiramatsu H; Hiramatsu K; Kitajima M
Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Jun; 60(7):379-88. PubMed ID: 10921297
[TBL] [Abstract][Full Text] [Related]
3. Functional MRI for anticancer therapy assessment.
Padhani AR
Eur J Cancer; 2002 Nov; 38(16):2116-27. PubMed ID: 12387837
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging of breast cancer angiogenesis: a review.
Furman-Haran E; Kelcz F; Degani H
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):47-54. PubMed ID: 12585654
[TBL] [Abstract][Full Text] [Related]
5. In vivo assessment of vascular endothelial growth factor-induced angiogenesis.
Lewin M; Bredow S; Sergeyev N; Marecos E; Bogdanov A; Weissleder R
Int J Cancer; 1999 Dec; 83(6):798-802. PubMed ID: 10597197
[TBL] [Abstract][Full Text] [Related]
6. Identification of angiogenesis in primary breast carcinoma according to the image analysis.
Kim SW; Park SS; Ahn SJ; Chung KW; Moon WK; Im JG; Yeo JS; Chung JK; Noh DY
Breast Cancer Res Treat; 2002 Jul; 74(2):121-9. PubMed ID: 12186372
[TBL] [Abstract][Full Text] [Related]
7. [Angiogenesis as a prognostic factor of breast cancers].
Kuroi K; Toi M
Nihon Rinsho; 2000 Apr; 58 Suppl():435-41. PubMed ID: 11026030
[No Abstract] [Full Text] [Related]
8. Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors.
Jia WR; Chai WM; Tang L; Wang Y; Fei XC; Han BS; Chen M
Eur J Radiol; 2014 Jul; 83(7):1098-1105. PubMed ID: 24794865
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor.
Pham CD; Roberts TP; van Bruggen N; Melnyk O; Mann J; Ferrara N; Cohen RL; Brasch RC
Cancer Invest; 1998; 16(4):225-30. PubMed ID: 9589031
[TBL] [Abstract][Full Text] [Related]
10. [Detection of angiogenesis-dependent parameters by functional MRI: correlation with histomorphology and evaluation of clinical relevance as prognostic factor using cervix carcinoma as an example].
Hawighorst H; Schaeffer U; Knapstein PG; Knopp MV; Weikel W; Schönberg SO; Essig M; van Kaick G
Rofo; 1998 Nov; 169(5):499-504. PubMed ID: 9849600
[TBL] [Abstract][Full Text] [Related]
11. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival.
Hawighorst H; Knapstein PG; Knopp MV; Weikel W; Brix G; Zuna I; Schönberg SO; Essig M; Vaupel P; van Kaick G
Cancer Res; 1998 Aug; 58(16):3598-602. PubMed ID: 9721867
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of tumor angiogenesis using dynamic enhanced magnetic resonance imaging: comparison of plasma vascular endothelial growth factor, hemodynamic, and pharmacokinetic parameters.
Ikeda O; Nishimura R; Miyayama H; Yasunaga T; Ozaki Y; Tuji A; Yamashita Y
Acta Radiol; 2004 Jul; 45(4):446-52. PubMed ID: 15323399
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor in cerebellar hemangioblastomas does not correlate with tumor angiogenesis.
Vaquero J; Zurita M; Coca S; Salas C; Oya S
Cancer Lett; 1998 Oct; 132(1-2):213-7. PubMed ID: 10397476
[TBL] [Abstract][Full Text] [Related]
14. Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts.
Bhujwalla ZM; Artemov D; Natarajan K; Ackerstaff E; Solaiyappan M
Neoplasia; 2001; 3(2):143-53. PubMed ID: 11420750
[TBL] [Abstract][Full Text] [Related]
15. Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights.
Turetschek K; Preda A; Novikov V; Brasch RC; Weinmann HJ; Wunderbaldinger P; Roberts TP
J Magn Reson Imaging; 2004 Jul; 20(1):138-44. PubMed ID: 15221819
[TBL] [Abstract][Full Text] [Related]
16. Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome.
Hawighorst H; Weikel W; Knapstein PG; Knopp MV; Zuna I; Schönberg SO; Vaupel P; van Kaick G
Clin Cancer Res; 1998 Oct; 4(10):2305-12. PubMed ID: 9796959
[TBL] [Abstract][Full Text] [Related]
17. A radicicol derivative, KF58333, inhibits expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor, angiogenesis and growth of human breast cancer xenografts.
Kurebayashi J; Otsuki T; Kurosumi M; Soga S; Akinaga S; Sonoo H
Jpn J Cancer Res; 2001 Dec; 92(12):1342-51. PubMed ID: 11749701
[TBL] [Abstract][Full Text] [Related]
18. Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours.
Vermeulen PB; Gasparini G; Fox SB; Colpaert C; Marson LP; Gion M; Beliën JA; de Waal RM; Van Marck E; Magnani E; Weidner N; Harris AL; Dirix LY
Eur J Cancer; 2002 Aug; 38(12):1564-79. PubMed ID: 12142044
[No Abstract] [Full Text] [Related]
19. Dynamic contrast-enhanced magnetic resonance imaging reveals stress-induced angiogenesis in MCF7 human breast tumors.
Furman-Haran E; Margalit R; Grobgeld D; Degani H
Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6247-51. PubMed ID: 8692800
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of angiogenic burden in human cancer xenografts using a perfusion-type optical contrast agent (SIDAG).
Wall A; Persigehl T; Hauff P; Licha K; Schirner M; Müller S; von Wallbrunn A; Matuszewski L; Heindel W; Bremer C
Breast Cancer Res; 2008; 10(2):R23. PubMed ID: 18331624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
